Etripamil Gets FDA Approval for At-Home Tachycardia Conversion

By News Health
1 day Ago

(MedPage Today) — The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), maker Milestone Pharmaceuticals announced.
The rapid-acting L-type calcium channel blocker is indicated…

Source link : https://www.medpagetoday.com/cardiology/arrhythmias/119016

Author :

Publish date : 2025-12-15 19:08:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Cardiologist Found Dead; Biological Aging and CVD Risk; New Coronary Clot Retriever

California Hires Ex-CDC Leaders Who Were Fired or Quit Under Trump

Ministers Promise Urgent Care Focus in NHS Dental Reform

Wound Care Scheme Yields Long Prison Sentences

Bispecific Antibody Induces High Response Rate in Metastatic TNBC

AI Model Stratifies Late Recurrence Risk in HR-Positive Breast Cancer